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Abstract A full-length cDNA encoding a novel human protein 
phosphatase 1 (PPI) binding subunit of molecular mass 36 kDa, 
termed PPP1R5, was sequenced. PPP1R5 shows 42% identity to 
the glycogen binding subunit (GL) of PP1 from rat liver and 28% 
identity to the N-terminal region of the glycogen binding suhunit 
(GM) of PP1 from human skeletal muscle. Like Gb PPP1R5 
modulates the specificity of PP1, but it differs from GL in being 
present in a wide variety of tissues, besides liver. The amino acid 
St~luence and properties of PPP1R5 indicate that it is not subject 
t~ the same modes of covalent and allosteric regulation by 
hormones as are G M and GL. 
l~ey words." Protein phosphatase 1; Glycogen metabolism; 
c!)NA; Chromosome 10 
1 Introduction 
Protein phosphatase 1 (PP1) participates in the regulation 
cf a wide variety of cellular functions by reversible protein 
Fhosphorylation and is one of the major protein phosphatases 
c!ephosphorylating serine and threonine residues in eukar- 
3 otes. The ability of PPI to regulate diverse functions resides 
ia the capacity of PP1 to interact with a variety of regulatory 
sabunits that may target PPI to specific subcellular locations, 
i mdulate its substrate specificity and allow its activity to be 
r~sponsive to extracellular signals [1]. 
A 126 kDa glycogen binding subunit (GM, PPP1R3) targets 
I'P1 to glycogen particles and to the sarcoplasmic reticulum in 
:riated muscle [2,3]. The hormones insulin and adrenalin are 
1 aought to influence the activity of PP1 via the GM subunit. 
t'hosphorylation f Ser-46 in human Gr~, in response to in- 
~,alin, enhances the rate at which PP1 dephosphorylates and 
~ ctivates glycogen synthase causing an increase in glycogen 
~ynthesis [4]. In contrast, phosphorylation f Ser-65 in human 
~}M by protein kinase A in response to ~-adrenergic agonists 
l riggers dissociation of PPI from Gra, thus inhibiting PPI 
'.rom acting on glycogen synthase and phosphorylase and re- 
ulting in decreased glycogen synthesis and stimulation of 
;lycogenolysis [5]. 
A distinct 33 kDa glycogen binding subunit (GL, PPP1R4), 
vhich is only 23% identical to the N-terminal portion of GM, 
argets PPI to glycogen in liver [6,7]. The binding of GL 
nodulates the activity of PP1, enhancing the rate at which 
t dephosphorylates and activates glycogen synthase and sup- 
i~ressing the rate at which it inactivates phosphorylase. Hor- 
'nonal regulation of the activity of PP1 in liver is not known 
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to occur through the phosphorylation of G1,. Instead, the 
hormone glucagon (acting via cyclic AMP and protein kinase 
A) and ct-adrenergic agonists (acting via Ca 2+) increase the 
levels of phosphorylase a, which to binds GL and potently 
inhibits PP1 at nanomolar concentrations. This inhibition is 
thought o be allosteric, since the Km for phosphorylase as a 
substrate of PP1 is in the micromolar ange. Insulin acts by 
lowering the level of cyclic AMP in liver, thereby decreasing 
the level of phosphorylase a and relieving the inhibition of the 
PPI GL complex. Glycogen synthesis in liver is also stimu- 
lated by glucose, which binds to phosphorylase a increasing 
the rate at which it is dephosphorylated. 
Several other targetting subunits of PPI have now been 
identified in mammals. These include the myosin binding tar- 
getting complex (comprising an Mlt0 and an M21 subunit) of 
smooth muscle, which enhances the dephosphorylation f
myosin light chains by PP1 and is involved in the relaxation 
of smooth muscle [8,9]. A distinct myosin targetting subunit 
of PPI is present in striated muscles [10]. A p53 binding pro- 
tein (53BP2) [11], a nuclear protein NIPP-1 [12] and an RNA 
splicing factor PSF1 [13] have been shown to bind to PP1. 
The retinoblastoma gene product [14], ribosomal proteins L5 
[15] and RIPP-1 [16] and a 110 kDa nuclear protein yet to be 
identified [17] are also reported to interact with PP1. The 
small cytosolic proteins, inhibitor-l, inhibitor-2 and 
DARPP-32, inhibit PP1 (reviewed in [18]). A complex be- 
tween inhibitor-2 and PP1 has been isolated. More recently, 
inhibitor-2 has been shown to act like a molecular chaperone 
to fold PP1 into its native conformation [19,20]. A number of 
distinct PP1 targetting subunits have also been identified in 
yeast (reviewed in [21]). 
Sites on the glycogen and myofibrillar targetting subunits 
which bind to PP1 have been localised [22] and a 13 residue 
peptide containing a small motif common to many of the PP1 
binding subunits has been crystallised as a complex with PP1 
[23]. Here we report a novel PP1 binding subunit, which we 
term PPP1R5 in accordance with the human genome nomen- 
clature [24], which contains the PPI binding motif, modulates 
the specificity of PP1 and is related to GL but has a much 
wider tissue distribution. 
2. Materials and methods 
2.1 Identification and sequence analysis of the cDNA encoding human 
protein phosphatase 1 binding subunit R5 
The Human Genome Sciences expressed sequence (EST) cDNA 
database, derived from over 500 human cDNA libraries [25,26], was 
searched for sequences related the rat liver glycogen binding subunit 
(G~) using the TBLASTN algorithm [27]. Four overlapping cDNA 
sequences, identified from different libraries, encoded part of a protein 
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with sequences similarities to rat GL, which we termed PPP1R5. One 
of these cDNAs, pHGBDX21, which encoded PPP1R5 and derived 
from a human gall bladder library, was completely sequenced in both 
directions on an Applied Biosystems 373A automated DNA sequencer 
using Taq dye terminator cycle sequencing. A liver eDNA kindly 
provided by the I.M.A.G.E. consortium, St. Louis, was also shown 
by sequence analysis to encode part of PPP1R5. The complete se- 
quence of PPP1R5 was searched against a more recent update of 
the EST library organised into overlapping assemblies, and this iden- 
tified 58 further ESTs which spanned the entire coding region and an 
additional 1379 nucleotides of the 3' untranslated region (UTR) not 
included in the original cDNA. Hence the entire mRNA would appear 
to be at least 2.5 kb. The extreme 3' sequence also overlapped two 
sequence tagged site sequences (STS identifiers: WI-11129 and TIGR- 
A004S47) which have been localised to chromosome 10q23 24 
(Whitehead/MIT Center). 
2.2. Expression of GST-R5 fusion protein in E. coli and production of 
antibodies 
The open reading of PPP1R5 was amplified by PCR using oligo- 
nucleotide 5'-GCGCCATATGAGCTGCACCAGAATGATC-3', 
which creates an NdeI site (underlined) at the initiating methionine 
codon, and oligonucleotide 5'-GCGCCTCGAGTCATCGATAA- 
GAGGCCAAGTTC-Y, which creates an Xhol site (underlined) just 
3' of the termination codon. The complete coding region of PPP1R5 
was cloned into the prokaryote gene fusion expression vector pGEX- 
AH [7,28]. The final construct termed, pGEX-PPP1R5, encoded glu- 
tathione S-transferase (GST) followed by the complete open reading 
frame of PPP1R5. The GST-R5 protein was expressed in E. coli and 
purified by affinity chromatography onglutathione-agarose (Sigma) as 
described in [7]. 250 gg of soluble GST-R5 was isolated per litre of 
bacterial culture. Antibodies to GST-R5 were raised in sheep and 
affinity purified. For measurement of the effect of PPP1R5 on the 
PP1 activity, contaminating GST in the GST-R5 preparation was 
removed by chromatography on Superdex 200 in 50 mM Tris-HC1 
pH 7.5, 0.03% Brij 35, 0.1% 2-mercaptoethanol. GST-R5 eluted as a 
dimer, probably because GST possesses a dimeric structure. 
2.3. Glutathione affinity precipitations 
Indicated amounts of GST-R5 and PP1 were incubated in 50 or 100 
gl of 50 mM Tris-HC1 pH 7.5, containing 150 mM NaCI, 0.1% (v/v) 
2-mercaptoethanol, 0.02% (v/v) Brij 35 and 0.1 mg/ml bovine serum 
albumin for 1 h at 4°C. 10 gl of glutathione-agarose (Sigma) was 
added and incubation was continued at 4°C with shaking for 30 
min. After centrifugation, the supernatant was removed and the pellet 
washed twice with 1 ml buffer (without albumin), then denatured by 
heating in SDS gel loading buffer at 95°C for 5 min and analysed by 
polyacrylamide gel electrophoresis. 
2.4. Protein phosphatase assays 
PP1 was human PPI'/I [29] expressed in E. coli and purified as 
described in [19]. Rabbit skeletal muscle glycogen phosphorylase (pre- 
pared by Miss F. Douglas) was 32P-labelled by phosphorylase kinase 
to a stoichiometry of 1 mol phosphate per mol subunit as in [30] and 
was 10 gM in the assays. Protein phosphatase assays were performed 
in the absence of divalent cations as described in [30]. One unit of 
activity is the amount of enzyme which catalyses the release of 1 /amol 
of [32P]phosphate p r minute. 
3. Results 
3.1. Human protein phosphatase 1 binding subunit R5 is related 
to, but not the homologue of rat liver glycogen binding 
subunit of PPI 
A search of the Human Genome Sciences EST database 
with the sequence of the glycogen binding subunit (GL) of 
c acgaggccgcgggggcaaggcctggagctg -61 
tggttcgaatt tgtgcaggcagcgggtgct ggcttttagggtccgccgcctctctgccta -i 
ATGAGC TGCACCAGAATGATC CAG~-~Tx-~-A GATCCACG CCTTTGACAAGTTCGGTCATG 60 
M S C T R M I Q V L D P R P L T S S V M 20 
CCCGTGGATGTGGC~TC~ GCACATTCACC~J~CTGTGAAGAGTTTCCTG 120 
P V D V A M R L C L A H S P P V K $ F L 40 
GGCCCGTACGATGAATTTCA~JCGACGACAT TTTGTGAATAAATTAAAGCCCCTGARATCA 180 
G P Y D E F Q R R H F V N K L K P L K S 60 
TGTCTCAATAT~CAAATCA CAGAA .CAACCAA 240 
C L N I K H K A K S Q N D W K C S H N Q 80 
GCCAAGAAGCGCGTTGTGTTTGCTGACTCC AAGGGCCTCT~GCGATCCATGTC 300 
A K K R V V F A D S K G L S L T A I H V 100 
TTCTCCGACCTCCCAGAAGAACCAGCGTGG GATCTGCAGTTTGATCTCTTGGACCTTAAT 360 
F S D L P E E P A W D L Q F D L L D L N 120 
GATATCTCCTCTGCCTTAAAACACCACGAG • ".L'~'x'AGATTTCCCTCAA 420 
D I S S A L K H H E E K N L I L D F P Q 140 
CCTTCAACCC~TTACTTAAGTTTC~ CAC T~'gGTCTGTCTGGAG 480 
P S T D Y L S F R S H F Q K N F V C L E 160 
~GCAAC- ,AC~GAACAGTGACA GGGACTG'TTAAAGTCAAAAATGTGA~.t"J.-.t-I ' 540 
N C S L Q E R T V T G T V K V K N V S F 180 
GAGAAGAAAGTTCAGATCCGTATCAC~x-~-£C GATTCTTGGAAAAACTACACTGACGTAGAC 600 
E K K V Q I R I T F D S W K N Y T D V D 200 
TGTGTCTATATGAAAAATGTGTATGGTGGC ~ T A G T G A T A C C T ~ ~  660 
C V Y M K N V Y G G T D S D T F S F A I 220 
GACTTACCCCCTGTCATTCCAACT~ AAAATTGAGTTCTGCATTTCTTACCATGCT 720 
D L P P V I P T E Q K I E F C I S Y H A 240 
AA~L..-J.-j.-z-x'C-C-C~.D_.AACAATC~T GGTCAGAATTATAGAATTGTTCATGTTCAA 780 
N G Q V F W D N N D G Q N Y R I V H V Q 260 
T G G A A G C C I " C ~ ~ T G  G C A C C C ~ ~ G  840 
W K P D G V Q T Q M A P Q D C A F H Q T 280 
TCTCCTAAGACAGAGTTA~AGTCAACAATC TTGGC~LTCCGAGGCTGGCTAGTGGGCTC 900 
S P K T E L E S T I F G S P R L A S G L 300 
TTCCCAGAGT TG GAGAACTTGGCCTCTTATCGATGAattaag 960 
F P E W Q S W G R M E N L A S Y R 317 
caacaa~J~taactggtcttgacttgtcata ttcccccat~caatcctaggtctgtattgc 1020 
tcaatt ttaggaagcct t tgctactccatc agtaggtttagatttga 1067 
Fig. 1. Complementary DNA and predicted protein sequence of the human protein phosphatase 1 binding subunit R5 (PPP1R5). 
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R5 MSCTRMIQVL DPRPLTSSVM PVDVAMRLCL AHSPPVKSFL GPYDEFQRRH 50 
I II: I I 
G L M AVDIEY . . . . . . . . . . .  SYS SMAPSLRRER 20 
R5 FVNKL . . . . .  KPLKSCLNI-  -KHKAKSQND WKCSHNQAKK ~=~!2SKGL 93 
I I:  I I1 :  I:  : I I I IH I - I I  II 
GI. FTFKISPKLN KPLRPCIQLG SKDEAGRMVA PTVQ~ RVSFADNQGL 70 
R5 SLTAIHVFSD LPEEPAWDLQ 
II : I I1 :  : I: 
C, L AL_TM~SE F--DDPLDIP 
FDLLDLNDIS SALKIHIEEI~I LILDF_PQPST 143 
I : :I I I I :IIIIIII 
FNITELLDNI VSLTTAESES FVLD~PSA 118 
RS D _YLSFRSHFQ ENFVCLRNCS LQERTVT~V _K~FEEX yQIRITFDSW 193 
I l l  II I I I I I l l l  I l :  : I l l  II I :  I l l  I II I l l : l  
G L D YLDF I~Q TNHVCrRNCV L I ~  ~ yKIRMTFDTW 168 
R5 KNYTDVDCV!' I~NVY _G~S D TFSFAI_DLP PVIPTEQKIE FCISYIIANGQ 243 
I :11 I I I I :1 :1  I I I I I  I II I : : I I : I I I I  
G L KS~TDFPCQX VKDTYA~SDR DTFSFDISLP EKIQSYERME FAVC_YE~ 218 
aS ~ _YRIVHVQWKP 
: l l  I I t II1 
G L SYWD_ S I!IK(~(N YRITRAELRS 
DGVQT~ DCAFHQTSPK TELESTIFG_S 293 
I I : III 
TQGI~TE . . . . . . . .  PYNGPD FGISFDQFGS 260 
R5 PRLASGLFPE WQSWGRMENL ASYR 317 
II II111 1 I I I : I 
GI. PRCSFGLFPE WPSYLGYEKL GPYY 284 
F g. 2. Comparison of the amino acid sequences of human protein phosphatase 1 binding subunit R5 with the glycogen binding subunit (GL) 
ol protein phosphatase 1 from rat liver. Identities are shown by vertical ines. Conservative amino acid changes are indicated by colons in the 
following groups (L, I, V); (A, G); (S, T); (D, E); (Q, N); (R, K); (F, Y, W). Residues that are identical in R5, G~. and PPPIR3 (G~) are 
underlined. The minimal PP1 binding motif is double underlined. 
P!~I from rat liver identified a number of partially sequenced 
cDNAs encoding a protein with significant sequence similarity 
t~ rat GI,. The complete sequence of the open reading frame 
e~coded by one of these cDNAs from human gall bladder is 
wesented in Fig. 1. The predicted protein is 36.4 kDa, com- 
wising 317 amino acids if the initiating methionine is at codon 
1 rather than at codon 6, 20 or 26. An in-frame termination 
c,~don precedes codon 1. However, nucleotide sequences im- 
n~ediately preceding codons 6, 20 or 26 conform more closely 
t,, the consensus equence for eukaryote translation initiation 
[>1] than that preceding codon 1. Translation may therefore 
sar t  at codon 6 giving rise to a protein of 35.8 kDa. 
The amino acid sequence of human PPPIR5 shows 42% 
i, entity to rat liver GL and 51% similarity if conservative 
s zbstitutions are taken into account (Fig. 2). PPP1R5 is less 
s milar to GM showing only 27% and 28% identity to the first 
2~5 amino acids of rabbit and human GM respectively. The 
1,,w degree of similarity of PPP1R5 to GL and GM indicates 
t la t  PPP1R5 is unlikely to be the human homologue of rat 
(,L. The glycogen binding subunits from human and rabbit 
s~eletal muscle show a much higher level of identity (7YY,,) to 
etch other [3]. The different tissue distributions of human 
t 'PPIR5 and rat G~ also indicate that these two proteins 
~re not species homologues. PPPIR5 cDNA was identified 
i i cDNA libraries from several adult tissues and cells, includ- 
i ~g gall bladder, prostate, osteoblasts, retina, smooth muscle, 
1 ver, kidney medulla, striatum and senescent fibroblasts, sev- 
eral fetal tissues including brain, lung, liver, heart, spleen and 
ttacenta, and turnout cells such as osteosarcoma, hepatocel- 
1 ,lar, ovarian and melanocyte tumour cells. In contrast, GL 
appears to be a liver-specific protein since its mRNA was 
present in liver but undetectable in lung, brain, heart, spleen, 
skeletal muscle, kidney and testis [7]. Affinity purified antibod- 
ies to GST-PPP1R5 recognised a 36 kDa protein on an lm- 
munoblot of rat liver and skeletal muscle extracts, whereas GL 
(33 kDa) was only detected in liver. A subsequent search of an 
assembled version of the EST database revealed an additional 
1.38 kb of 3' UTR suggesting an overall mRNA size of more 
than 2.5 kb. The 3' UTR overlapped the sequences of two 
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Fig. 3. Comparison of the effects of the GST-R5 and GST-GL on 
the phosphorylase phosphatase activity of protein phosphatase 1. 
The catalytic subunit (PPIT) was diluted in assay buffer to 1.5 U/ml 
(1.4 nM), and a 0.01 ml aliquot was incubated for 15 min at 30°C 
with 0.01 ml of the indicated concentrations of the purified bacte- 
rially expressed GST-R5, GST-GL or GST diluted in the same buf- 
fer. Assays were initiated with 0.01 ml 32P-labelled phosphorylase. 
The phosphorylase phosphatase activities of PPI in the presence of 
GST-R5 (open squares) and GST-GL (filled circles) and GST (open 
triangles) are shown. Activities are presented as a percentage of the 
initial PP1 activity. 
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Fig. 4. Comparison of the binding of phosphorylase a to GST-GL and GST-R5. GST-R5 and GST-GL were electrophoresed on a 10% poly- 
acrylamide gel, transferred to nitrocellulose membranes and probed with (A) 32P-labelled phosphorylase a as described in [6,7] or (B) stained 
with Coomassie blue. The positions of GST-R5, GST-GL and GST are indicated. Lane 1, affinity purified GST-GL; lane 2, affinity purified 
GST-R5; lane 3, GST-R5 after gel filtration on Superdex 200. The molecular mass markers are phosphorylase b (97 kDa), bovine serum albu- 
min (66 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa) and soybean trypsin inhibitor (20 kDa). 
sequence tagged sites, which allows the gene for PPPIR5 to be 
localised to chromosome 10q23-24. 
3.2. Human PPPIR5 coprecipitates with PP1 and modulates 
the substrate specificity of PP1 
In order to determine whether PPP1R5 would bind to PP1 
we expressed R5 in E. coli as a GST fusion protein (Fig. 4), 
incubated the purified GST-R5 with bacterially expressed PP1 
and performed precipitation studies using glutathione-agarose 
beads as described in Section 2.3. SDS polyacrylamide gel 
analysis of the pellets showed that PP1 was precipitated in 
the presence of GST-R5 and GSH-agarose beads but not in 
control incubations containing only PPI and GSH agarose 
(data not shown). 
Affinity purified GST-R5 inhibited the phosphorylase phos- 
phatase activity of PP1 as observed previously for GST-GL 
[7]. The amount of inhibition varied with the different prep- 
arations of GST-R5 and GST-GL, probably due to the ag- 
gregation of both protein preparations ( ee Section 4). Fig. 3 
shows that inhibition observed with freshly prepared prepara- 
tions of GST-R5 and GST-GL was similar with an IC50 of 
approximately 100 nM. Removal of GST, which was a major 
contaminant of the PPPlR5 preparation, did not significantly 
affect the IC~0. 
The glycogen synthase phosphatase activity of the complex 
of PP1 with GL is inhibited by phosphorylase a, the inhibition 
being achieved by the binding of phosphorylase a to the GL 
subunit [7]. PPP1R5 was therefore tested for its ability to bind 
phosphorylase a. Fig. 4 shows that phosphorylase a bound to 
GST-GL but it did not bind to GST-R5, indicating that R5 is 
distinct from GL in this property and is not regulated by 
phosphorylase a. 
4. D iscuss ion  
The human protein PPPIR5 identified here is most closely 
related to the rat liver glycogen binding subunit (GL) of PP1, 
but the fairly low sequence identity to GL and much wider 
tissue distribution indicate that it is unlikely to be the human 
homologue of GL. PPP1 R5 also differs from GL in that it does 
not bind phosphorylase a, which is known to regulate the 
activity of the PP1GL complex. Coprecipitation studies dem- 
R5 
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% 
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R5 231 - - -K IEFC I S ~  =N~EX~NYRI 256 
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Fig. 5. A putative carbohydrate binding domain identified from sequence similarities between PPP1R5, rat GL [7], human Gu [3], S. cerevisiae 
GAC1 [33] and Rhizopus oryzae glucoamylase (AMYL) [32]. Amino acids that are conserved in all five proteins are underlined and those that 
are identical are double underlined. 
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onstrated that PPPIR5 will form a complex with PP1 and 
inspection of the sequence of PPPIR5 shows that it possesses 
th, z RVXF motif (double underlined in Fig. 2), which is in- 
volved in the binding of GM and GL to PP1 [23] and is com- 
mon to a number of other PP1 binding proteins [24]. PPPIR5 
therefore represents a novel PP1 binding protein. 
PPP1R5 and GL show similar inhibition of phosphorylase 
pl osphatase activity. Therefore like other regulatory subunits 
o~ PPI, PPPIR5 may modulate the specificity of PPI towards 
p: rticular substrates. The identification of cDNAs encoding 
P!'PIR5 in a large number of different issues including liver 
i~:licates that, unlike GL which is liver specific, and GM which 
is found in muscles (skeletal, diaphragm and heart), PPP1R5 
p ovides a function common to many tissues. At present it is 
n,~t known whether PPP1R5 binds to glycogen, because the 
a!;gregation properties of PPP1R5 (and GL) cause it to pellet 
o l  centrifugation i both the presence and absence of glyco- 
g~ n. However, PPP1R5 does contains a region (amino acids 
1 '0-181) homologous to a postulated glycogen binding site in 
(M [1]. Interestingly an extensive region of PPP1R5, which 
d )es not contain the RVXF PP1 binding site, is conserved in 
l,t~izopus oryzae glucoamylase, an enzyme which is secreted 
flora the fungus and degrades tarch [32]. An alignment of 
PPP1R5 (amino acids 157-256), GL, G~, S. cerevisiae GACI 
[~'3] and R. orvzae glucoamylase (amino acids 33 129) is 
stown in Fig. 5. Since amino acids 26-109 of R. oryzae glu- 
c ~amylase have been shown to adsorb to raw starch [32], and 
( r, GM and GACI all bind to glycogen, it seems likely that 
1: ~rt or all of the section shown in Fig. 5 may be a carbohy- 
c :ate binding domain. S. cerevisiae GIP2, a PPI binding pro- 
t~ in whose function is unknown, has also recently been shown 
t ,  align to part of this region [34]. PPP1R5 may therefore be 
i~tvolved in the regulation of glycogen metabolism in a wide 
t mge of tissues, besides liver and muscle. However, the hor- 
r tonal regulation of PPP1R5 must differ from that of GM and 
( ~L. Neither of the serine residues that are phosphorylated in
iM in response to insulin and adrenalin are conserved in 
I'PP1R5, nor is the phosphorylase a binding site which is 
i wolved in the allosteric regulation of GL by hormones. 
1 urther studies will be required to ascertain whether or not 
IPP IR5  is hormonally regulated. 
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